Search Results for "AmBisome"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for AmBisome. Results 1 to 7 of 7 total matches.
See also: amphotericin B
Isavuconazonium Sulfate (Cresemba) - A New Antifungal
The Medical Letter on Drugs and Therapeutics • Mar 14, 2016 (Issue 1490)
treatment has not been
well established.1 A lipid formulation of amphotericin
B (AmBisome, Abelcet ...
The FDA has approved isavuconazonium sulfate
(Cresemba – Astellas) for intravenous and oral treatment
of invasive aspergillosis and invasive mucormycosis
in adults. Isavuconazonium sulfate is a prodrug of
isavuconazole, a broad-spectrum triazole antifungal.
Miltefosine (Impavido) for Leishmaniasis
The Medical Letter on Drugs and Therapeutics • Sep 15, 2014 (Issue 1451)
– Liposomal amphotericin
B (AmBisome) is the treatment of choice for visceral
leishmaniasis in the US.2 ...
The FDA has approved miltefosine (Impavido – Knight
Therapeutics), an oral alkylphosphocholine analog,
for treatment of visceral, cutaneous, and mucosal
leishmaniasis caused by some Leishmania species.
It is the first drug to be approved by the FDA for
treatment of cutaneous and mucosal leishmaniasis
and the first oral drug to be approved for treatment of
visceral leishmaniasis.
Antifungal Drugs
Treatment Guidelines from The Medical Letter • Aug 01, 2012 (Issue 120)
amphotericin B
(AmBisome) 3-5 mg/kg/d; amphotericin B cholesteryl sulfate (Amphotec) 3-4 mg/kg/d ...
The drugs of choice for treatment of fungal infections
are listed in the table that begins on page 62. Some of
the indications and dosages recommended here have
not been approved by the FDA. More detailed guidelines
for some of these infections are available online
from the Infectious Diseases Society of America
(www.idsociety.org).
Rezafungin (Rezzayo) for Invasive Candida Infections
The Medical Letter on Drugs and Therapeutics • Jun 24, 2024 (Issue 1705)
amphotericin B – 50 mg single-use vials 3-5 mg/kg IV once/day3
AmBisome (Astellas) 15143.00
1. In patients ...
The FDA has approved rezafungin (Rezzayo – Cidara/Melinta), an intravenous echinocandin antifungal, for
once-weekly treatment of candidemia and invasive
candidiasis (IC) in adults with limited or no alternative
options. It is the first new drug to become available
in the US in more than 15 years for treatment of
systemic Candida infections.
Med Lett Drugs Ther. 2024 Jun 24;66(1705):101-4 doi:10.58347/tml.2024.1705d | Show Introduction Hide Introduction
Micafungin (Mycamine) for Fungal Infections
The Medical Letter on Drugs and Therapeutics • Jun 20, 2005 (Issue 1211)
amphotericin B (L-AmB) –
AmBisome (Astellas) 3-5 mg/kg/d 28,848.75
Amphotericin B lipid complex (ABLC ...
Micafungin sodium (Mycamine - Astellas), the second echinocandin antifungal to become available in the US, has been approved by the FDA for intravenous treatment of esophageal candidiasis and prophylaxis of invasive Candida infections in patients undergoing hematopoietic stem cell transplantation (HSCT).
Anidulafungin (Eraxis) for Candida Infections
The Medical Letter on Drugs and Therapeutics • May 22, 2006 (Issue 1235)
(L-AmB) –
AmBisome (Astellas) 3-5 mg/kg/d IV 3-5 mg/kg/d IV 1287.51
Amphotericin B lipid complex ...
Anidulafungin (ay nid yoo la fun jin; Eraxis - Pfizer), a third intravenous echinocandin antifungal, has been approved by the FDA for treatment of esophageal candidiasis, candidemia, and other complicated Candida infections (intra-abdominal abscess or peritonitis).
Drugs for Parasitic Infections
Treatment Guidelines from The Medical Letter • Aug 01, 2013 (Issue 143)
With increasing travel, immigration, use of immunosuppressive drugs and the spread of AIDS, physicians
anywhere may see infections caused by parasites. The table in this document lists first-choice and alternative drugs for most
parasitic infections.